MGRC inks collaborations to grow base in Thailand

TheEdge Fri, Sep 23, 2022 01:47pm - 4 days View Original


KUALA LUMPUR (Sept 23): Malaysian Genomics Resource Centre Bhd (MGRC) has inked a series of collaborations to grow its customer base in Thailand, as well as explore opportunities for research and development of new products and services.

In a bourse filing on Friday (Sept 23), the genomics and biopharmaceutical specialist said it had signed a supply and collaboration agreement with Acquest Healthcare Stem Cell Research and Development Co Ltd to produce CAR T-cells for supply to Acquest’s customers.

It said Acquest is a provider of various cell therapies to hospitals, specialist doctors, and patients in Thailand, operating a state-of-the-art clinical laboratory, and is also the largest privately-owned specialty human cell culturing facility in the country.

MGRC also signed a supply and collaboration agreement with Salus Holdings Co Ltd to supply biopharmaceutical and genomics products and services to Salus’ customers.

Salus provides wellness and health screening using science and technology for early disease detection, managing programmes for lifestyle intervention based in Bangkok, Thailand.

Lastly, MGRC signed a letter of intent with Marine Group Co Ltd and Salus on collaborative research in the use of genetic screening tests and formulated cosmetic products containing certain cell therapy ingredients for the regeneration of skin and hair of patients.

MGRC said Marine Group is an aesthetic and wellness provider, with a network of over 42 centres under the brands of Slim Up, Skin Doctors, and Biocell.

MGRC chief executive officer Sasha Nordin said the collaborations are part of its strategy of growing its customer base, and increasing presence overseas through working with business partners with an established presence in their respective market segments.

At the midday break on Friday, MGRC settled 4.2% or three sen higher at 74.5 sen, with 5.64 million shares done.

The content is a snapshot from Publisher. Refer to the original content for accurate info. Contact us for any changes.






Related Stocks

MGRC 0.720

Comments

Login to comment.